House Bill 817

AN ACT TO REQUIRE THE STATE DEPARTMENT OF HEALTH TO ESTABLISH THE CANADIAN PRESCRIPTION DRUG IMPORTATION PROGRAM; TO DEFINE CERTAIN TERMS FOR THE PURPOSE OF THE ACT; TO REQUIRE THE DEPARTMENT TO CONTRACT WITH A VENDOR TO FACILITATE WHOLESALE PRESCRIPTION DRUG IMPORTATION UNDER THE PROGRAM; TO SPECIFY THE RESPONSIBILITIES FOR THE VENDOR, INCLUDING THE PAYMENT OF A BOND; TO PROVIDE ELIGIBILITY CRITERIA FOR PRESCRIPTION DRUGS, CANADIAN SUPPLIERS, AND IMPORTERS UNDER THE PROGRAM; TO AUTHORIZE A CANADIAN SUPPLIER TO EXPORT DRUGS INTO THIS STATE UNDER THE PROGRAM UNDER CERTAIN CIRCUMSTANCES; TO PROVIDE ELIGIBILITY CRITERIA AND REQUIREMENTS FOR DRUG IMPORTERS; TO REQUIRE PARTICIPATING CANADIAN SUPPLIERS AND IMPORTERS TO COMPLY WITH SPECIFIED FEDERAL REQUIREMENTS FOR DISTRIBUTING PRESCRIPTION DRUGS IMPORTED UNDER THE PROGRAM; TO PROHIBIT CANADIAN SUPPLIERS AND IMPORTERS FROM DISTRIBUTING, DISPENSING, OR SELLING PRESCRIPTION DRUGS IMPORTED UNDER THE PROGRAM OUTSIDE OF THIS STATE; TO REQUIRE THE DEPARTMENT TO REQUEST FEDERAL APPROVAL OF THE PROGRAM AND REQUIRE THE REQUEST TO INCLUDE CERTAIN INFORMATION; TO REQUIRE THE DEPARTMENT TO BEGIN OPERATING THE PROGRAM WITHIN SIX MONTHS AFTER RECEIVING FEDERAL APPROVAL; TO PROVIDE FOR CERTAIN DOCUMENTATION REQUIREMENTS FOR VENDORS; TO REQUIRE THE DEPARTMENT TO SUSPEND THE IMPORTATION OF DRUGS IN VIOLATION OF THIS ACT OR ANY FEDERAL OR STATE LAW OR REGULATION; TO AUTHORIZE THE DEPARTMENT TO REVOKE THE SUSPENSION UNDER CERTAIN CIRCUMSTANCES; TO REQUIRE THE DEPARTMENT TO SUBMIT AN ANNUAL REPORT TO THE GOVERNOR AND THE LEGISLATIVE OFFICERS BY A SPECIFIED DATE AND PROVIDE REQUIREMENTS FOR SUCH REPORT; TO REQUIRE THE DEPARTMENT TO NOTIFY LEGISLATIVE OFFICERS UPON FEDERAL APPROVAL OF THE PROGRAM AND TO SUBMIT A PROPOSAL TO THE LEGISLATURE FOR PROGRAM IMPLEMENTATION AND FUNDING BEFORE A CERTAIN DATE; TO REQUIRE THE DEPARTMENT TO ADOPT RULES DEEMED NECESSARY TO IMPLEMENT THIS ACT; AND FOR RELATED PURPOSES.

In the House of Representatives

• Becky Currie

  Sponsor

l9n doesn't hold this bill's text yet.

In the House of Representatives Jan 31 – Mar 5

1. Jan 31Referred to the House committees on Drug Policy and on Public Health and Human Services
2. Mar 5Died in committee in the House